Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Linde
LIN
|
+$299M |
| 2 |
General Dynamics
GD
|
+$129M |
| 3 |
Cigna
CI
|
+$86.9M |
| 4 |
CVS Health
CVS
|
+$75M |
| 5 |
Amazon
AMZN
|
+$46.9M |
Top Sells
| 1 |
AET
Aetna Inc
AET
|
+$234M |
| 2 |
Northrop Grumman
NOC
|
+$218M |
| 3 |
ESRX
Express Scripts Holding Company
ESRX
|
+$170M |
| 4 |
PX
Praxair Inc
PX
|
+$168M |
| 5 |
COL
Rockwell Collins
COL
|
+$116M |
Sector Composition
| 1 | Technology | 18.92% |
| 2 | Healthcare | 16.26% |
| 3 | Consumer Discretionary | 11.53% |
| 4 | Communication Services | 10.14% |
| 5 | Industrials | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HIFR
1701
DELISTED
InfraREIT, Inc.
HIFR
| $1.63M | ﹤0.01% |
77,700
+1,300
| +2% | +$27.3K |
|
1702
Garrett Motion
GTX
$2.65B
| $1.63M | ﹤0.01% |
+132,100
| New | +$1.63M |
|
|
PGTI
1703
DELISTED
PGT, Inc.
PGTI
| $1.62M | ﹤0.01% |
102,400
+2,000
| +2% | +$31.7K |
|
|
GLUU
1704
DELISTED
Glu Mobile Inc.
GLUU
| $1.62M | ﹤0.01% |
200,600
+4,900
| +3% | +$39.5K |
|
1705
Atkore
ATKR
$2.08B
| $1.62M | ﹤0.01% |
81,400
-1,300
| -2% | -$25.8K |
|
1706
Materion
MTRN
$2.37B
| $1.61M | ﹤0.01% |
35,800
+900
| +3% | +$40.5K |
|
|
AIMT
1707
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $1.61M | ﹤0.01% |
67,174
+2,700
| +4% | +$64.6K |
|
1708
TTM Technologies
TTMI
$5.1B
| $1.61M | ﹤0.01% |
165,000
+4,600
| +3% | +$44.7K |
|
1709
Fresh Del Monte Produce
FDP
$1.7B
| $1.6M | ﹤0.01% |
56,700
| – | – |
|
1710
Sunrun
RUN
$3.8B
| $1.6M | ﹤0.01% |
147,050
+7,000
| +5% | +$76.2K |
|
|
KEM
1711
DELISTED
KEMET Corporation
KEM
| $1.6M | ﹤0.01% |
91,300
+3,100
| +4% | +$54.4K |
|
|
WPG
1712
DELISTED
Washington Prime Group Inc.
WPG
| $1.6M | ﹤0.01% |
36,552
+756
| +2% | +$33.1K |
|
|
TBI
1713
Trueblue
TBI
$184M
| $1.6M | ﹤0.01% |
71,800
-1,300
| -2% | -$28.9K |
|
1714
Kadant
KAI
$3.7B
| $1.6M | ﹤0.01% |
19,600
+400
| +2% | +$32.6K |
|
1715
Workiva
WK
$4.38B
| $1.59M | ﹤0.01% |
44,421
+1,800
| +4% | +$64.6K |
|
1716
Mr. Cooper
COOP
$14.1B
| $1.59M | ﹤0.01% |
+136,500
| New | +$1.59M |
|
1717
Varex Imaging
VREX
$477M
| $1.59M | ﹤0.01% |
67,240
+1,700
| +3% | +$40.3K |
|
|
CLVS
1718
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.59M | ﹤0.01% |
88,450
+1,400
| +2% | +$25.2K |
|
1719
Adeia
ADEA
$1.7B
| $1.59M | ﹤0.01% |
325,836
| – | – |
|
1720
Tennant Co
TNC
$1.5B
| $1.58M | ﹤0.01% |
30,400
+900
| +3% | +$46.9K |
|
1721
TFS Financial
TFSL
$3.72B
| $1.58M | ﹤0.01% |
98,000
| – | – |
|
|
BPFH
1722
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $1.58M | ﹤0.01% |
149,500
+2,300
| +2% | +$24.3K |
|
|
GRP.U
1723
Granite Real Estate Investment Trust
GRP.U
$3.39B
| $1.58M | ﹤0.01% |
40,400
| – | – |
|
1724
Southside Bancshares
SBSI
$909M
| $1.58M | ﹤0.01% |
49,618
+1,000
| +2% | +$31.7K |
|
1725
Atlanta Braves Holdings Series B
BATRK
$2.61B
| $1.57M | ﹤0.01% |
63,229
+900
| +1% | +$22.4K |
|